Regulatory issues
暂无分享,去创建一个
[1] K. Kraemer,et al. Normal vitamin D levels can be maintained despite rigorous photoprotection: six years' experience with xeroderma pigmentosum. , 1997, Journal of the American Academy of Dermatology.
[2] E. Birch,et al. Impact of Early Dietary Intake and Blood Lipid Composition of Long-Chain Polyunsaturated Fatty Acids on Later Visual Development , 2000, Journal of pediatric gastroenterology and nutrition.
[3] David Moher,et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. , 2003, Clinical chemistry.
[4] Joseph F. Noferi,et al. Creating effective biopharmaceutical QA/QC organizations : Your people are the key , 2002 .
[5] G. FitzGerald,et al. The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension. , 1989, The New England journal of medicine.
[6] P. Howe. Dietary Fats and Hypertension Focus on Fish Oil , 1997, Annals of the New York Academy of Sciences.
[7] R. Mensink,et al. Compartmental modeling to quantify alpha-linolenic acid conversion after longer term intake of multiple tracer boluses. , 2005, Journal of lipid research.
[8] J. L. Dahl,et al. Pain management, controlled substances, and state medical board policy: a decade of change. , 2002, Journal of pain and symptom management.
[9] S. Wittenberg. Solar radiation and the eye: a review of knowledge relevant to eye care. , 1986, American journal of optometry and physiological optics.
[10] Grant M. Carrow,et al. Pain management and prescription monitoring. , 2002, Journal of pain and symptom management.
[11] Kristin Shrader-Frechette,et al. Risk analysis and scientific method , 1985 .
[12] I. Feller,et al. Scientific and Technological Information in State Legislatures , 1979 .
[13] E. Schmidt,et al. Long-term supplementation with n-3 fatty acids, I: Effect on blood lipids, haemostasis and blood pressure. , 1992, Scandinavian journal of clinical and laboratory investigation.
[14] R. Steinbrook. Physician-assisted suicide in Oregon--an uncertain future. , 2002, The New England journal of medicine.
[15] Dai Fukumura,et al. Tissue engineering: Creation of long-lasting blood vessels , 2004, Nature.
[16] A. Gilson,et al. Pharmacists' knowledge of and attitudes toward opioid pain medications in relation to federal and state policies. , 2001, Journal of the American Pharmaceutical Association.
[17] M. O'hare,et al. Searching for Safety , 1990 .
[18] R. Setlow,et al. Wavelengths effective in induction of malignant melanoma. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[19] Roger Clarke. Who is liable for software errors? Proposed new product liability law in Australia , 1989, Comput. Law Secur. Rev..
[20] B. Rumack,et al. Human overdose with the veterinary tranquilizer xylazine. , 1986, The American journal of emergency medicine.
[21] H. Olsson,et al. Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity , 2000, British Journal of Cancer.
[22] U. Wester,et al. An Analysis of UVA Emissions from Sunlamps and the Potential Importance for Melanoma , 1998, Photochemistry and photobiology.
[23] C. S. Hill,et al. Government regulatory influences on opioid prescribing and their impact on the treatment of pain of nonmalignant origin. , 1996, Journal of pain and symptom management.
[24] P. Whelton,et al. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. , 1993, Archives of internal medicine.
[25] D. Grobbee,et al. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials , 2002, Journal of hypertension.
[26] M. Law,et al. Plant sterol and stanol margarines and health , 2000, BMJ : British Medical Journal.
[27] J C Juskevich,et al. Bovine growth hormone: human food safety evaluation. , 1990, Science.
[28] C. J. Louis,et al. Drug abuse with inhalated xylazine , 2003, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.
[29] C. Schroeder. Rights Against Risks , 1986 .
[30] A. Gilson,et al. Controlled substances and pain management: changes in knowledge and attitudes of state medical regulators. , 2001, Journal of pain and symptom management.
[31] J. L. Dahl. State cancer pain initiatives. , 1993, NIDA research monograph.
[32] R. Gibson,et al. A Critical Appraisal of the Role of Dietary Long-Chain Polyunsaturated Fatty Acids on Neural Indices of Term Infants: A Randomized, Controlled Trial , 2000, Pediatrics.
[33] Xavier Castellsagué,et al. Against which human papillomavirus types shall we vaccinate and screen? the international perspective , 2004, International journal of cancer.
[34] Alan D. Woolf,et al. Abuse of Telazol: An Animal Tranquilizer , 2001, Journal of toxicology. Clinical toxicology.
[35] H. Olsson,et al. Use of sunbeds or sunlamps and malignant melanoma in southern Sweden. , 1994, American journal of epidemiology.
[36] Paul W. Allen,et al. Survival guide to FDA inspections. Part 1, To prepare or not to prepare, there is no question , 2002 .
[37] J. Hansen,et al. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. , 1997, The American journal of clinical nutrition.
[38] Michael J Lysaght,et al. Tissue engineering: the end of the beginning. , 2004, Tissue engineering.
[39] D G Altman,et al. REporting recommendations for tumour MARKer prognostic studies (REMARK) , 2005, British journal of cancer.
[40] M. Allman-Farinelli,et al. Replacement of linoleic acid with α-linolenic acid does not alter blood lipids in normolipidaemic men , 1998, British Journal of Nutrition.
[41] P. Autier,et al. Cutaneous malignant melanoma and exposure to sunlamps or sunbeds: An eortc multicenter case‐control study in Belgium, France and Germany , 1994 .
[42] R Scott Obach,et al. SEEING THROUGH THE MIST: ABUNDANCE VERSUS PERCENTAGE. COMMENTARY ON METABOLITES IN SAFETY TESTING , 2005, Drug Metabolism and Disposition.
[43] C. Hertzman,et al. The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. , 1990, American journal of epidemiology.
[44] E. Birch,et al. Visual Acuity and the Essentiality of Docosahexaenoic Acid and Arachidonic Acid in the Diet of Term Infants , 1998, Pediatric Research.
[45] Talbot Page,et al. A Generic View of Toxic Chemicals and Similar Risks , 1978 .
[46] B. Diffey,et al. The erythemal response of human skin to ultraviolet radiation , 1985, The British journal of dermatology.
[47] S. Linder,et al. Enforcement costs and regulatory reform: The agency and firm response , 1984 .
[48] T. O'Leary,et al. Food and Drug Administration regulation of in vitro diagnostic devices. , 2005, The Journal of molecular diagnostics : JMD.
[49] R. Gregory,et al. Public perceptions of electric power transmission lines , 1988 .
[50] B. Rosner,et al. The effect of fish oil on blood pressure in mild hypertensive subjects: a randomized crossover trial. , 1993, The American journal of clinical nutrition.
[51] F. Sacks,et al. Does Fish Oil Lower Blood Pressure? A Meta‐Analysis of Controlled Trials , 1993, Circulation.
[52] H. Beecher,et al. Ethics and clinical research. , 1966, The New England journal of medicine.
[53] Stephen G. Breyer,et al. Regulation and its reform , 1982 .
[54] Mackie,et al. Sunbeds in current use in Scotland: a survey of their output and patterns of use , 1998, The British journal of dermatology.
[55] M. Weinstock,et al. Do tanning lamps cause melanoma? An epidemiologic assessment. , 1998, Journal of the American Academy of Dermatology.
[56] R. Kanner. Opioids for severe pain: little change over 15 years. , 2001, Journal of pain and symptom management.
[57] G. Fritz,et al. Propofol dependency in a lay person. , 2002, Anesthesiology.
[58] Sheila Jasanoff,et al. Risk management and political culture , 1986 .
[59] T. Brennan,et al. Legal and scientific probability of causation of cancer and other environmental disease in individuals. , 1985, Journal of health politics, policy and law.
[60] R. Hendel,et al. A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. , 2005, Journal of the American College of Cardiology.
[61] Toshio Shimizu. Health claims on functional foods: the Japanese regulations and an international comparison , 2003, Nutrition Research Reviews.